
TNDM · NASDAQ
Tandem Diabetes Care, Inc.
$20.00 +0.95 (+4.99%)
Company overview
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises the t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and Control-IQ technology, t:slim X2 with G5 integration, and the Tandem Device Updater, a tool that allows users to update their pump's software.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $1.4B
- Employees
- 2,650
- Headquarters
- San Diego, CA
- Website
- tandemdiabetes.com
- CEO
- John F. Sheridan
- Listed
- November 14, 2013
- P/E
- -14.22
- Dividend yield
- 0.00%
Company financials
- Revenue
- $1B
- Gross profit
- $564M
- Operating income
- -$81M
- EBITDA
- -$75.6M
- Net income
- -$94.5M
- EPS
- -$1.40
- Total assets
- $1.2B
- Total debt
- $735M
- Gross margin
- 54.93%
- Net margin
- -9.20%
- Earnings yield
- -7.03%
Showing FY 2025
News